The use of KIAA0551 polypeptides and polynucleotides in the design of protocols for the treatment of neuropathies, neuropathic pain, inflammatory and chronic pain, neurodegenerative conditions such as Motor Neuron Disease, Parkinson's Disease, Alzheimer's Disease and other dementias, as well as ischaemic damage in neuronal and cardiac tissues, through disease or infectious agents, among others, and diagnostic assays for such conditions. Also disclosed are methods for producing such polypeptides by recombinant techniques.

L'uso dei polipeptidi KIAA0551 e dei polynucleotides nel disegno dei protocolli per il trattamento dei neuropathies, del dolore infiammatorio e cronico neuropathic di dolore, termini neurodegenerative quali la malattia del neurone del motore, la malattia del Parkinson, la malattia del Alzheimer ed altre demenze, così come danni ischemici in tessuti di un neurone e cardiaci, attraverso la malattia o gli agenti contagiosi, tra altre ed analisi diagnostiche per tali termini. Inoltre sono rilevati i metodi per produrre tali polipeptidi mediante tecniche recombinant.

 
Web www.patentalert.com

< (none)

< Method for design and selection of efficacious antisense oligonucleotides

> KVLQT1--a long QT syndrome gene

> (none)

~ 00012